Related Experiment Video

Updated: Jul 24, 2026

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique
09:47

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique

Published on: April 26, 2015

K(ATP) channel activation reduces the severity of postresuscitation myocardial dysfunction

W Tang1, M H Weil, S Sun

  • 1Institute of Critical Care Medicine, Palm Springs 92262, California, USA.

American Journal of Physiology. Heart and Circulatory Physiology
|September 29, 2000
PubMed

Insights

Ischemic preconditioning and ATP-sensitive K(+) (K(ATP)) channel activation significantly improve heart function after cardiac arrest. Blocking K(ATP) channels negates these protective effects, indicating K(ATP) channel activation mediates preconditioning benefits.

Area of Science:

  • Cardiology
  • Physiology
  • Pharmacology

Background:

  • Postresuscitation myocardial dysfunction contributes to high mortality rates after cardiac arrest.
  • Understanding mechanisms to improve myocardial function post-resuscitation is critical.

Purpose of the Study:

  • To investigate the effects of ischemic preconditioning and ATP-sensitive K(+) (K(ATP)) channel activation on postresuscitation myocardial function.
  • To determine if K(ATP) channel activation mediates the protective effects of ischemic preconditioning.

Main Methods:

  • Ventricular fibrillation (VF) was induced in Sprague-Dawley rats, followed by cardiopulmonary resuscitation (CPR) and defibrillation.
  • Animals were randomized into five groups: ischemic preconditioning, K(ATP) channel opener, preconditioning with K(ATP) blocker, K(ATP) blocker alone, and placebo.
  • Postresuscitation myocardial function and survival were assessed.

Main Results:

  • Both ischemic preconditioning and K(ATP) channel opener significantly improved postresuscitation myocardial function and survival.
  • Administration of a K(ATP) channel blocker 45 minutes before preconditioning abolished the protective effects.
  • These findings suggest K(ATP) channel activation is essential for the benefits of ischemic preconditioning.

Conclusions:

  • Ischemic preconditioning enhances myocardial function and survival after CPR.
  • The cardioprotective effects of ischemic preconditioning are mediated through the activation of K(ATP) channels.

More Related Videos

Murine Isolated Heart Model of Myocardial Stunning Associated with Cardioplegic Arrest08:30

Murine Isolated Heart Model of Myocardial Stunning Associated with Cardioplegic Arrest

Published on: August 6, 2015

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Related Concept Videos

G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
Muscle Recovery and Fatigue01:24

Muscle Recovery and Fatigue

Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective response...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...